pharmaphorum

NOVEMBER 8, 2022

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. Tighter glucose control is known to reduce the risk of complications of diabetes like cardiovascular disease and nerve damage affecting the eyes and extremities.

Diabetes 64

Diabetes Communication 64

European Pharmaceutical Review

DECEMBER 15, 2022

At least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), mainly Africa, are set to benefit from Eli Lilly and Company and manufacturer EVA Pharmaceutical’s new collaboration delivering a sustainable supply of high-quality, affordable human and analogue insulin to this population.

Diabetes 97

Diabetes Packaging Communication 97

Express Pharma

AUGUST 4, 2023

At Novo Nordisk, we are dedicated to tackling chronic diseases by driving change in diabetes, obesity, rare diseases- haemophilia, growth hormone deficiency, etc., Simplifying diabetes care, awareness around obesity and related complications, CVDs and rare diseases like haemophilia continue to be the focus areas for the Indian market.

Diabetes 98

Diabetes Communication 98

European Pharmaceutical Review

JANUARY 27, 2023

.” “Efforts to expand access to medicines, especially insulin, are only beneficial when effective cold chain systems are in place to keep them at the right temperature on their way to patients,” commented Leigh Ann Pusey, Executive Vice President of corporate affairs and communications for Lilly.

Communication 105

Communication Diabetes 105

pharmaphorum

MARCH 2, 2022

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. billion in 2020 to more than $16 billion by 2030, according to GlobalData.

Diabetes 52

Diabetes Communication 52

Pharmaceutical Technology

JANUARY 11, 2023

By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Digital therapeutic apps are being built to help manage type 2 diabetes or assist with addiction. The global market size is estimated to be more than $95.3bn 1.

Health and Personal Care Stores 52

Health and Personal Care Stores Hospitals Communication Medical Records 52

PharmD Live

MAY 13, 2024

Their projections indicate that approximately 10,000 people will turn 65 each day over the next 19 years, with the population of older adults expected to double to 80 million by 2030. At this rate, nearly half of the older population could be impacted by polypharmacy by 2030. Data from the U.S. in 1994 to 42.4%

Long-Term Care Facilities 105

Long-Term Care Facilities Diabetes Nursing Homes Prescription Filling 105